Popular on s4story
- New Memoir Takes Readers Along on a Post-Retirement Travel Journey - 190
- Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd - 188
- Akiti the Hunter Launches Mission to Deliver One Million Books to One Million Children Worldwide
- Intuitive Numerologist, Yvonne Sullivan, Publishes the Ultimate Guide to the NOC Divination System
- Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
- Sun Gate Golf Retirement Community Doesn't have a Shuffleboard. It Solves Murder Mysteries
- Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
- Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
- Share Your Story Event: Your Voice, Your Story
- FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
Similar on s4story
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Mandeville Pests May Pose Serious Health Risks for Your Family
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
- Redefining Proactive Care: The Rise of the Hybrid Concierge Medical Model
Registration Opens for the Inaugural HPAPI USA Conference
S For Story/10377231
Launch of Highly Potent Active Pharmaceutical Ingredients USA Conference
BOSTON - May 16, 2019 - s4story -- SMi reports: Registration is now open for the HPAPI USA conference, taking place in Boston on the 21st-22nd October 2019.
The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
With this in mind, SMi Group are pleased to present the inaugural HPAPI USA conference, taking place in Boston on the 21st-22nd October 2019.
The two-day event will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning to improve risk assessment and validation, as well as the latest emerging therapies including bispecific antibodies, oncolytic viral complexes and hormones.
More on S For Story
For those interested in attending, there is a $400 early bird discount on bookings expiring on May 31st, 2019 https://www.smi-online.co.uk/pharmaceuticals/northamerica/hpapi-usa
Key Highlights include:
• Oncology Antibody-Drug Conjugates (ADC), the ongoing developments and the containment challenges imposed
• How to correctly assess, plan and implement the most cost-effective containment
• Emerging HPAPI therapies, oncolytic viruses their potential and challenges
• Alternative HPAPI manufacturing technologies to reduce powder exposure and improving safety along with enabling continuous manufacturing
• The reality of oncology ADC and HPAPI: are most drugs using 'highly-potent' to improve brand image? Has 50 years of ADC R&D for oncology with no cure shows signs of no promise?
The agenda features presentations from key opinion leaders from all areas of pharmaceuticals and biologicals to share strategies on developing containment, formulation and manufacturing for maximum HPAPI success.
More on S For Story
Chairs for 2019:
• Janet Gould, Senior Managing Toxicologist, SafeBridge Consultants USA
• Rakesh Dixit, Vice President of R&D Global Head, MedImmune; Vice President of R&D Translational Sciences – Biologics Safety Assessment, AstraZeneca
Featured speakers include:
• Charlyn Reihman, Principal Occupational Health Consultant, SafeBridge Consultants USA
• David Eherts, Vice President, Global EHS, Allergan
• Keith Jensen, Owner and Consultant, Keith Jensen Consulting, Formerly at Novartis-MIT Center for Continuous Manufacturing
• Tony Haight, Director of Process Chemistry, AbbVie
• Sara Martens, Senior Manager EHS Technical Operations, AbbVie
The event brochure with the full agenda and speaker line-up is available to download online.
HPAPI USA 2019 is proudly sponsored by Lonza and SafeBridge Consultants, Inc.
SMi offer unique sponsorship, exhibition and branding packages, tailored to complement your company's marketing strategy. Contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk
For media enquiries contact Neill Howard on Tel: +44 (0)20 7827 6164 / Email: nhoward@smi-online.co.uk
HPAPI USA
Conference: 21st- 22nd October 2019
Workshops: 23rd October 2019
Sheraton Boston Hotel, Boston, USA
#smihpapi-usa
The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
With this in mind, SMi Group are pleased to present the inaugural HPAPI USA conference, taking place in Boston on the 21st-22nd October 2019.
The two-day event will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning to improve risk assessment and validation, as well as the latest emerging therapies including bispecific antibodies, oncolytic viral complexes and hormones.
More on S For Story
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- "For the Love of God" Audiobook by Michael Finney Now Available
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
For those interested in attending, there is a $400 early bird discount on bookings expiring on May 31st, 2019 https://www.smi-online.co.uk/pharmaceuticals/northamerica/hpapi-usa
Key Highlights include:
• Oncology Antibody-Drug Conjugates (ADC), the ongoing developments and the containment challenges imposed
• How to correctly assess, plan and implement the most cost-effective containment
• Emerging HPAPI therapies, oncolytic viruses their potential and challenges
• Alternative HPAPI manufacturing technologies to reduce powder exposure and improving safety along with enabling continuous manufacturing
• The reality of oncology ADC and HPAPI: are most drugs using 'highly-potent' to improve brand image? Has 50 years of ADC R&D for oncology with no cure shows signs of no promise?
The agenda features presentations from key opinion leaders from all areas of pharmaceuticals and biologicals to share strategies on developing containment, formulation and manufacturing for maximum HPAPI success.
More on S For Story
- Speak Empowered Welcomes Author Eli Brackenbury as First Speaker in Faith & Purpose Category
- BookBuzz Interviews Author Daniela Hristova About Her New Memoir – Fluent in Faux Pas
- The Measure of Heaven: Lunar Calendars, Solar Calendars and the Birth of the Modern Cosmos
- Bruce Goldwell Announces New Book Exploring One of Humanity's Oldest Questions
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
Chairs for 2019:
• Janet Gould, Senior Managing Toxicologist, SafeBridge Consultants USA
• Rakesh Dixit, Vice President of R&D Global Head, MedImmune; Vice President of R&D Translational Sciences – Biologics Safety Assessment, AstraZeneca
Featured speakers include:
• Charlyn Reihman, Principal Occupational Health Consultant, SafeBridge Consultants USA
• David Eherts, Vice President, Global EHS, Allergan
• Keith Jensen, Owner and Consultant, Keith Jensen Consulting, Formerly at Novartis-MIT Center for Continuous Manufacturing
• Tony Haight, Director of Process Chemistry, AbbVie
• Sara Martens, Senior Manager EHS Technical Operations, AbbVie
The event brochure with the full agenda and speaker line-up is available to download online.
HPAPI USA 2019 is proudly sponsored by Lonza and SafeBridge Consultants, Inc.
SMi offer unique sponsorship, exhibition and branding packages, tailored to complement your company's marketing strategy. Contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk
For media enquiries contact Neill Howard on Tel: +44 (0)20 7827 6164 / Email: nhoward@smi-online.co.uk
HPAPI USA
Conference: 21st- 22nd October 2019
Workshops: 23rd October 2019
Sheraton Boston Hotel, Boston, USA
#smihpapi-usa
Source: SMi Group Ltd
0 Comments
Latest on S For Story
- Johnnie Mandela Releases THOUGHT in the Age of AI
- Michelle Ian Releases New Horror Suspense Thriller - Shadows Are Falling
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
- Rogue Fae Brings the Prophecy of a Fae Trilogy to an Epic Conclusion
- New Book Brings Decades of Clinical Research to the Addiction Recovery Crisis
- French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
- Casa Carlini Introduces AI-Powered Chat Support for Website Visitors
- LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
- New Children's Book 'Where Love Goes' Helps Kids Understand Death, Grief, Cremation, and Love
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Award-Winning Epic Fantasy New Blood Saga Expanding from Eight to Nine Books
- King Tides: Jason Jeffries Lowcountry Thriller Is Now Available
- Casa Carlini Relaunches Carlini Points with a Smarter, Simpler Rewards Experience
- Jenn Bouchard receives national recognition through the NYC BIG BOOK AWARD®!